4D Molecular Therapeutics In

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.61

-0.37 (-4.12%)

As of Mar 22, 10:23 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 82%

Hold 3 18%

Sell 0 0%

Price Target

Analyst Price Target +145.2% upside

Low Target $12.84

Average Target $21.11

High Target $26.25

Current Price $8.61

Current
$8.61

Target
$21.11

$12.84 $21.11 avg $26.25

Scenario Analysis

Bear Case

$12.84

49.1%

Low target

Base Case

$21.11

+145.2%

Avg target

Bull Case

$26.25

+204.9%

High target

Risk/Reward

4.2x

Highly favorable

Price in Context

52-Week High

$12.34

-30.2% from high

52-Week Low

$2.24

+285.2% from low

Target vs 52W High

$21.11

+71.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%